Hub Gene Verification and Diagnostic Ability Assessment Indicated That CD4, UGT2B7, and CYP3A4 may be the Potential Diagnostic Biomarkers of Non-alcoholic Fatty Liver Disease–Hepatocellular Carcinoma. Here, UGT2B7 is linked to metabolic dysfunction-associated steatotic liver disease.